Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode

Journal of Molecular Biology

Volumn 407, Issue 1, 2011, Pages 13-20

  Zhang, Haitao ^a   Li, Li ^b   Chen, Lili ^a   Hu, Lihong ^a   Jiang, Hualiang ^a   Shen, Xu ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

agonist; bigelovin; cancer; crystal structure; RXR

Indexed keywords

BIGELOVIN; FARNESOID X RECEPTOR; LIVER X RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RECEPTOR BLOCKING AGENT; RETINOID X RECEPTOR ALPHA; STEROID RECEPTOR COACTIVATOR 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG BINDING; DRUG POTENCY; DRUG STRUCTURE; LIGAND BINDING; PRIORITY JOURNAL;

EID: 79952006933     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.01.032     Document Type: Article

References (43)

1. Germain P., Chambon P., Eichele G., Evans R.M., Lazar M.A., and Leid M. International Union of Pharmacology. LXIII. Retinoid X receptors Pharmacol. Rev. 58 2006 760 772 (Pubitemid 44833744)
2. De Lera A.R., Bourguet W., Altucci L., and Gronemeyer H. Design of selective nuclear receptor modulators: RAR and RXR as a case study Nat. Rev. Drug Discov. 6 2007 811 820 (Pubitemid 47504872)
3. Michalik L., Auwerx J., Berger J.P., Chatterjee V.K., Glass C.K., and Gonzalez F.J. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors Pharmacol. Rev. 58 2006 726 741 (Pubitemid 44833742)
4. Lee F.Y., Lee H., Hubbert M.L., Edwards P.A., and Zhang Y. FXR, a multipurpose nuclear receptor Trends Biochem. Sci. 31 2006 572 580 (Pubitemid 44436939)
5. Mitro N., Mak P.A., Vargas L., Godio C., Hampton E., and Molteni V. The nuclear receptor LXR is a glucose sensor Nature 445 2007 219 223 (Pubitemid 46095727)
6. Altucci L., Leibowitz M.D., Ogilvie K.M., de Lera A.R., and Gronemeyer H. RAR and RXR modulation in cancer and metabolic disease Nat. Rev. Drug Discov. 6 2007 793 810 (Pubitemid 47504871)
7. Amos B., and Lotan R. Retinoid-sensitive cells and cell lines Methods Enzymol. 190 1990 217 225
8. Brown P.H., Subbaramaiah K., Salmon A.P., Baker R., Newman R.A., and Yang P. Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid Cancer Prev. Res. (Phila. Pa) 1 2008 208 214
9. Dragnev K.H., Petty W.J., Shah S., Biddle A., Desai N.B., and Memoli V. Bexarotene and erlotinib for aerodigestive tract cancer J. Clin. Oncol. 23 2005 8757 8764 (Pubitemid 46211521)
10. Dragnev K.H., Petty W.J., Ma Y., Rigas J.R., and Dmitrovsky E. Nonclassical retinoids and lung carcinogenesis Clin. Lung Cancer 6 2005 237 244 (Pubitemid 40309334)
11. Kim H.T., Kong G., Denardo D., Li Y., Uray I., and Pal S. Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays Cancer Res. 66 2006 12009 12018 (Pubitemid 46094215)
12. Li Y., Zhang Y., Hill J., Kim H.T., Shen Q., and Bissonnette R.P. The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice Br. J. Cancer 98 2008 1380 1388 (Pubitemid 351543584)
13. Zanardi S., Serrano D., Argusti A., Barile M., Puntoni M., and Decensi A. Clinical trials with retinoids for breast cancer chemoprevention Endocr.-Relat. Cancer 13 2006 51 68
14. Renaud J.P., and Moras D. Structural studies on nuclear receptors Cell. Mol. Life Sci. 57 2000 1748 1769
15. Shulman A.I., and Mangelsdorf D.J. Retinoid x receptor heterodimers in the metabolic syndrome N. Engl. J. Med. 353 2005 604 615 (Pubitemid 41138942)
16. Mangelsdorf D.J., Kliewer S.A., Kakizuka A., Umesono K., and Evans R.M. Retinoid receptors Recent Prog. Horm. Res. 48 1993 99 121
17. Gronemeyer H., Gustafsson J.A., and Laudet V. Principles for modulation of the nuclear receptor superfamily Nat. Rev. Drug Discov. 3 2004 950 964 (Pubitemid 39534319)
18. Kassam A., Miao B., Young P.R., and Mukherjee R. Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding J. Biol. Chem. 278 2003 10028 10032 (Pubitemid 36800256)
19. Cesario R.M., Klausing K., Razzaghi H., Crombie D., Rungta D., Heyman R.A., and Lala D.S. The rexinoid LG100754 is a novel RXR:PPARγ agonist and decreases glucose levels in vivo Mol. Endocrinol. 15 2001 1360 1369 (Pubitemid 32703483)
20. Gampe R.T. Jr, Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K., and Milburn M.V. Asymmetry in the PPARγ/RXRα crystal structure reveals the molecular basis of heterodimerization among nuclear receptors Mol. Cell 5 2000 545 555
21. Johnson B.S., Chandraratna R.A., Heyman R.A., Allegretto E.A., Mueller L., and Collins S.J. Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor α403 heterodimers is developmentally regulated during myeloid differentiation Mol. Cell. Biol. 19 1999 3372 3382 (Pubitemid 29193797)
22. Egea P.F., Mitschler A., and Moras D. Molecular recognition of agonist ligands by RXRs Mol. Endocrinol. 16 2002 987 997 (Pubitemid 34478536)
23. Nahoum V., Perez E., Germain P., Rodriguez-Barrios F., Manzo F., and Kammerer S. Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function Proc. Natl Acad. Sci. USA 104 2007 17323 17328 (Pubitemid 350219841)
24. Egea P.F., Mitschler A., Rochel N., Ruff M., Chambon P., and Moras D. Crystal structure of the human RXRα ligand-binding domain bound to its natural ligand: 9-cis retinoic acid EMBO J. 19 2000 2592 2601 (Pubitemid 30323548)
25. Zhang T., Xiao W., Gong T., Yang Y., Chen R.Y., and Yu D.Q. Two new eudesmanolides from Inula racemosa J. Asian Nat. Prod. Res. 12 2010 788 792
26. College J.N.M. A Dictionary of Traditional Chinese Drug 1977 Shanghai Scientific and Technological Press Shanghai, China
27. Shan J.J., Yang M., and Ren J.W. Anti-diabetic and hypolipidemic effects of aqueous-extract from the flower of Inula japonica in alloxan-induced diabetic mice Biol. Pharm. Bull. 29 2006 455 459
28. Wang Q., Zhou B.N., Zhang R.W., Lin Y.Y., Lin L.Z., Gil R.R., and Cordell G.A. Cytotoxicity and NMR spectral assignments of ergolide and bigelovin Planta Med. 62 1996 166 168 (Pubitemid 26163224)
29. Zhang L., Liu W., Hu T., Du L., Luo C., and Chen K. Structural basis for catalytic and inhibitory mechanisms of β-hydroxyacyl-acyl carrier protein dehydratase (FabZ) J. Biol. Chem. 283 2008 5370 5379
30. Zeng G.Z., Tan N.H., Ji C.J., Fan J.T., Huang H.Q., Han H.J., and Zhou G.B. Apoptosis inducement of bigelovin from Inula helianthus-aquatica on human Leukemia U937 cells Phytother. Res. 23 2009 885 891
31. Li X., Hansen P.A., Xi L., Chandraratna R.A., and Burant C.F. Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor γ and retinoic acid X receptors J. Biol. Chem. 280 2005 38317 38327 (Pubitemid 43860306)
32. Putcha B.D., and Fernandez E.J. Direct interdomain interactions can mediate allosterism in the thyroid receptor J. Biol. Chem. 284 2009 22517 22524
33. Fujii S., Ohsawa F., Yamada S., Shinozaki R., Fukai R., and Makishima M. Modification at the acidic domain of RXR agonists has little effect on permissive RXR-heterodimer activation Bioorg. Med. Chem. Lett. 20 2010 5139 5142
34. Greschik H., and Moras D. Structure-activity relationship of nuclear receptor-ligand interactions Curr. Top. Med. Chem. 3 2003 1573 1599
35. Cao L.Q., Wang X.L., Wang Q., Xue P., Jiao X.Y., and Peng H.P. Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARγ signaling pathway Acta Pharmacol. Sin. 30 2009 1316 1322
36. Chen A., and Xu J. Activation of PPARγ by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR Am. J. Physiol.: Gasterointest. Liver Physiol. 288 2005 G447 G456
37. Tontonoz P., and Spiegelman B.M. Fat and beyond: the diverse biology of PPARγ Annu. Rev. Biochem. 77 2008 289 312
38. Minor Z.O. a. W Processing of X-ray diffraction data collected in oscillation mode C.W. Carter Jr R.M. Sweet, Methods in Enzymology: Macromolecular Crystallography: Part A 276 1997 Academic Press New York, NY 307 326
39. Collaborative Computational Project, Number 4 The CCP4 suite: programs for protein crystallography Acta Crystallogr., Sect. D: Biol. Crystallogr. 50 1994 760 763
40. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., and Grosse-Kunstleve R.W. Crystallography & NMR system: a new software suite for macromolecular structure determination Acta Crystallogr., Sect. D: Biol. Crystallogr. 54 1998 905 921
41. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 60 2004 2126 2132 (Pubitemid 41742764)
42. DeLano W.L. The PyMOL Molecular Graphics System on World Wide Web http://www.pymol.org 2002
43. Love J.D., Gooch J.T., Benko S., Li C., Nagy L., and Chatterjee V.K. The structural basis for the specificity of retinoid-X receptor-selective agonists: new insights into the role of helix H12 J. Biol. Chem. 277 2002 11385 11391 (Pubitemid 34952905)